TK Nucera stock gains 2.35 percent as report date is set

Published on 10/06/2026 at 14:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TK Nucera stock traded at EUR 8.70 on Xetra on October 6, 2026, with EUR 1.1 billion market value. Q3 revenue was EUR 145.0 million, down 21%, before its next report on February 10, 2027.

Schwarzweiß-Reportagefoto von Arbeitern vor industrieller Elektrolyseanlage mit Rohren — ThyssenKrupp Nucera (DE000NCA0001) zeigt Techniker in Schutzkleidung vor einer Elektrolyse-Industrieanlage in Schwarzweiß, Illustration mit AI erstellt.

TK Nucera (ISIN DE000NCA0001) stock was trading at EUR 8.70 on Xetra at 1:44 p.m. CEST on October 6, 2026, up 2.35% from the previous close. The company set February 10, 2027, for its next quarterly or interim statement, according to thyssenkrupp nucera on October 6, 2026.

February report date is confirmed

The scheduled disclosure gives the stock a defined reporting checkpoint after the company reported its third quarter and nine-month figures for fiscal 2025/26 in August. The same investor calendar lists an Annual Report for fiscal 2025/26 on December 16, 2026, providing an earlier date for a fuller assessment of the business.

The current move also follows a China contract announced on September 29. According to FinanzNachrichten, the Hongniu Lanzhou project covers licensing, engineering, procurement services, key components and commissioning support for a new chlor-alkali plant in northwest China.

Revenue falls while profitability improves

Q3 2026 revenue was EUR 145.0 million, down 21% from Q3 2025, while net income was EUR 0.0 million. Simply Wall St reports that nine-month fiscal 2025/26 revenue reached EUR 354.0 million and the group EBIT loss narrowed to EUR 69.0 million.

That combination matters for the next report: sales are still contracting year over year, but the quarterly bottom line has moved to break-even. The China order adds commercial support to the profitable chlor-alkali operation, while green hydrogen project timing remains central to the wider earnings path.

Analyst target adds a counterpoint

Simply Wall St also reports that analysts lowered a price target to EUR 7.60 from EUR 8.20 in an update dated October 5, 2026. The target sits below the EUR 8.70 intraday price, contrasting with the company's new order activity and the scheduled reporting dates.

The market value was EUR 1.1 billion on October 6, 2026. At EUR 8.70, the stock was 26.9% below its 52-week high of EUR 11.90 and EUR 1.83 above its 52-week low of EUR 6.87.

TK Nucera stock stays below yearly high

TK Nucera stock was trading at EUR 8.70 on Xetra on October 6, 2026, at 1:44 p.m. CEST, with a 2.35% daily gain and 5,707 shares traded. The upcoming February report will show whether the order pipeline and chlor-alkali base are translating into firmer group results.